LYRA THERAPEUTICS INC (LYRA)
US55234L1052 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -68.87M | -62.68M | -55.28M | -43.51M | -22.13M | |||
| Depreciation Amortization | 134.00K | 278.00K | 1.07M | 1.00M | 100.00K | |||
| Change In Working Capital | -5.49M | -4.88M | 4.56M | 13.92M | -880.00K | |||
| Other non cash items | 4.33M | 3.98M | 6.27M | 2.77M | 1.77M | |||
| OPERATING CASH FLOW | -69.91M | -63.30M | -43.39M | -25.82M | -21.14M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.15M | -1.05M | -160.00K | -3.39M | -1.78M | |||
| Other Investing Activity | -6.89M | -11.54M | -64.84M | N/A | N/A | |||
| INVESTING CASH FLOW | -10.05M | -12.58M | -65.01M | -3.39M | -1.78M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 78.16M | 69.34M | 100.50M | 600.00K | 90.29M | |||
| Other Financing Activity | -3.82M | -3.65M | -4.25M | -250.00K | -2.59M | |||
| FINANCING CASH FLOW | 74.33M | 65.69M | 96.26M | 360.00K | 87.70M | |||
| CHANGE IN CASH | -5.62M | -10.20M | -12.14M | -28.85M | 64.78M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -69.91M | -63.30M | -43.39M | -25.82M | -21.14M | |||
| Capital Expenditure | -3.15M | -1.05M | -160.00K | -3.39M | -1.78M | |||
| FREE CASH FLOW | -73.06M | -64.35M | -43.55M | -29.21M | -22.92M | |||
All data in USD